“To Evaluate the Efficacy of Teneligliptin As an Add-on Therapy in Type 2 Diabetes Mellitus (T2DM) Patients With Inadequate Glycemic Control With a Stable Dose of Metformin 1 to 2g and Glimipride 1 to 6mg Per Day ”. Academia Journal of Medicine 4, no. 2 (September 25, 2024): 61–66. Accessed April 4, 2025. https://journals.acspublisher.com/index.php/ajm/article/view/18911.